Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy
Status:
Recruiting
Trial end date:
2024-06-20
Target enrollment:
Participant gender:
Summary
This prospective, open-label, single-arm study will evaluate the efficacy and safety of
azacitidine in combination with chidamide in treatment of newly diagnosed peripheral T-cell
lymphoma unfit for conventional chemotherapy.